Evidence map›Paper›PMID 25355489›Full record

ArticleJournal of molecular neuroscience : MN2015

Accumulation of cytoplasmic glucocorticoid receptor is related to elevation of FKBP5 in lymphocytes of depressed patients.

Iva Lukic, Milos Mitic, Ivan Soldatovic, Milica Jovicic, Nadja Maric, Jelena Radulovic, Miroslav Adzic

Abstract read
In one paragraph

Article in Journal of molecular neuroscience : MN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Iva LukicLaboratory of Molecular Biology and Endocrinology, VINCA Institute of Nuclear Sciences, University of Belgrade, P.O. Box-522-MBE090, 11001, Belgrade, Serbia, iwa@vinca.rs.
Milos Mitic
Ivan Soldatovic
Milica Jovicic
Nadja Maric
Jelena Radulovic
Miroslav Adzic
University of Belgrade · RSCentar za Promociju Nauke · RSNorthwestern University · US

Funding

Preclinical and Patient Studies of Affective Disorders in SerbiaR21MH098793 · NIMH · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RADULOVIC, JELENA · 2014 to 2015
$235k
NIMH NIH HHS 1R21MH098793-01A1NIMH NIH HHS R21 MH098793
6 · The paper itself

Abstract

We have previously shown that patients with the major depressive disorder (MDD) exhibited elevated phosphorylation of the lymphocyte glucocorticoid receptor (GR) at serine 226 (S226). Here, we further analyse potential alterations of GR signalization in lymphocytes of MDD patients, i.e. the cytoplasmic/nuclear distribution of GR, levels of FK506-binding protein 5 (FKBP5) and glucocorticoid-induced leucine zipper (GILZ). The FKBP5 acts as an important regulator of GR activation, by decreasing ligand binding and impeding translocation of the receptor to the nucleus, while GILZ mediates glucocorticoid anti-inflammatory effects. Our result showed that the depressed patients had significantly higher GR levels in the cytoplasm compared to controls, which was accompanied by higher FKBP5 levels. Linear regression model demonstrated significantly higher correlation between FKBP5 and cytoplasmic GR than the presence of MDD itself or phosphorylation of nuclear GR at S226. There were no differences in the levels of GILZ isoforms. Therefore, the results suggest that accumulation of the GR in cytoplasm is related to the elevation of FKBP5, adding one more step in understanding altered GR signalling in lymphocytes, and potentially brain tissue, of MDD patients.

Indexed as

Protein Processing, Post-TranslationalActive Transport, Cell NucleusAdultCase-Control StudiesCell NucleusCytoplasmFemaleHumansLymphocytesMajor Depressive DisorderMaleMiddle AgedPhosphorylationProtein IsoformsReceptors, GlucocorticoidSignal TransductionProtein IsoformsReceptors, GlucocorticoidTacrolimus Binding Protein 5Tacrolimus Binding ProteinsTranscription FactorsTSC22D3 protein, human

Identifiers

PMID25355489
PMCPMC4881874
OpenAlexW2064245474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.